Top menu


  1. Pasqualucci L and Zhang B. Genetic drivers of NF-κB deregulation in diffuse large B-cell lymphoma. Semin Cancer Biol. 2016, 39: 26-31.
  2. Ba Z, Meng FL, Gostissa M, Huang PY, Ke Q, Wang Z, Dao MN, Fujiwara Y, Rajewsky K, Zhang B, and Alt FW. A Rapid Embryonic Stem Cell-Based Mouse Model for B-cell Lymphomas Driven by Epstein-Barr Virus Protein LMP1. Cancer Immunol Res. 2015, 3(6): 641-9.
  3. Zhang B, Calado DP, Wang Z, Frohler S, Kochert K, Qian Y, Koralov S, Schmidt-Supprian M, Sasaki Y, Unitt C, Rodig S, Chen W, Dalla-Favera R, Alt FW, Pasqualucci L, Rajewsky K. An Oncogenic Role for Alternative NF-kB Signaling in DLBCL Revealed upon Deregulated BCL6 Expression. Cell Reports. 2015, 11(5): 715-26.
  4. Yasuda T, Wirtz T, Zhang B, Wunderlich T, Schmidt-Supprian M, Sommermann T, Rajewsky K. Studying Epstein-Barr Virus Pathologies and Immune Surveillance by Reconstructing EBV Infection in Mice. Cold Spring Harb Symp Quant Biol. 2013, 78: 259-63.
  5. Sander S, Calado, DP, Srinivasan L, Kochert K, Zhang B, Rosolowski M, Rodig S, Holzmann K, Stilgenbauer S, Siebert R, Bullinger L, Rajewsky K. Synergy between PI3K Signalling and MYC in Burkitt Lymphomagenesis. Cancer Cell. 2012, 22(2): 167-79.
  6. Zhang B, Kracker S, Yasuda T, Casola S, Vanneman M, Hömig-Hölzel C, Wang Z, Derudder E, Li S, Chakraborty T, Cotter SE, Koyama S, Currie T, Freeman GJ, Kutok JL, Rodig SJ, Dranoff G, Rajewsky K. Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr-Virus Protein LMP1 in a Mouse Model. Cell. 2012, 148(4): 739-51.
  7. Calado DP, Zhang B, Srinivasan L, Sasaki Y, Seagal J, Unitt C, Rodig S, Kutok J, Tarakhovsky A, Schmidt-Supprian M, Rajewsky K. Constitutive canonical NF-kB activation cooperates with disruption of Blimp1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma. Cancer Cell. 2010, 18(6): 580-9.
  8. Yang L, Cui H, Wang Z, Zhang B, Ding J, Liu L, Ding HF. Loss of Negative Feedback Control of Nuclear Factor-kappaB2 Activity in Lymphocytes Leads to Fatal Lung Inflammation. Am J Pathol. 2010, 176(6): 2646-57.
  9. Srinivasan L, Sasaki Y, Calado DP, Zhang B, Paik JH, DePinho RA, Kutok JL, Kearney JF, Otipoby KL, Rajewsky K. PI3 kinase signals BCR-dependent mature B cell survival. Cell. 2009, 139(3): 573-86.
  10. Sasaki Y, Calado DP, Derudder E, Zhang B, Shimizu Y, Mackay F, Nishikawa SI, Rajewsky K, Schmidt-Supprian M. NIK-overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells. Proc Natl Acad Sci USA. 2008, 105(31): 10883-8.
  11. Wang Z, Zhang B, Yang L, Ding J, Ding HF. Constitutive production of NF-kB2 p52 is not tumorigenic but predisposes mice to inflammatory autoimmune disease by repressing Bim expression. J Biol Chem. 2008, 283(16): 10698-706.
  12. Xiao C, Srinivasan L, Calado DP, Patterson HC, Zhang B, Wang J, Henderson JM, Kutok JL, Rajewsky K. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol. 2008, 9(4): 405-14.
  13. Zhang B, Wang Z, Li T, Tsitsikov EN, Ding HF. NF-kB2 mutation targets TRAF1 to induce lymphomagenesis. Blood. 2007, 110(2): 743-51.
  14. Zhang B, Wang Z, Ding J, Peterson P, Gunning WT, Ding HF. NF-kB2 is required for the control of autoimmunity by regulating the development of medullary thymic epithelial cells. J Biol Chem. 2006, 281(50): 38617-24.